Clinical bottom line
Dietary interventions remain a cornerstone in the management of nonalcoholic fatty liver disease (NAFLD), with evidence supporting weight loss and specific nutritional modifications to improve liver fat content, inflammation, and metabolic parameters. Mediterranean-style diets, reduced saturated fat intake, and increased consumption of polyunsaturated fatty acids (PUFAs) and polyphenols show promise in ameliorating NAFLD progression. However, individualized approaches considering patient comorbidities and preferences are essential. While dietary modification alone can improve outcomes, sustained lifestyle changes and multidisciplinary support optimize long-term benefits (Pouwels et al., 2022; Zeng et al., 2024).
What the evidence shows
Pouwels et al. (2022) provide a comprehensive review highlighting that weight loss of 7–10% body weight is associated with significant reductions in hepatic steatosis and fibrosis markers. Dietary patterns emphasizing whole foods, low glycemic index carbohydrates, and healthy fats contribute to these improvements.
Zeng et al. (2024) present an international multidisciplinary expert consensus underscoring the role of dietary modification in preventing and managing metabolic dysfunction-associated fatty liver disease (MAFLD), recommending Mediterranean and plant-based diets rich in antioxidants and anti-inflammatory nutrients.
Jeyakumar et al. (2019) focus on n-3 PUFA supplementation, demonstrating reductions in liver fat content and improvements in lipid profiles, supporting omega-3 fatty acids as adjunctive therapy.
Lee et al. (2019) review polyphenols’ protective actions, including modulation of oxidative stress and inflammation, suggesting dietary polyphenol intake may slow NAFLD progression.
Cai et al. (2019) summarize nutritional interventions, noting that calorie restriction combined with balanced macronutrient intake improves insulin sensitivity and liver enzymes.
Rinella et al. (2015) provide a systematic review confirming that lifestyle interventions, particularly diet and exercise, remain first-line therapy for NAFLD, though adherence challenges persist.
Polyzos et al. (2019) discuss obesity’s pathophysiological link to NAFLD and the therapeutic potential of dietary and pharmacologic interventions targeting metabolic pathways.
Tincopa et al. (2023) emphasize the need for individualized dietary counseling and ongoing support to sustain behavioral changes in NAFLD patients.
Caveats and uncertainty
Most dietary studies are limited by small sample sizes, short durations, and heterogeneity in intervention protocols.
Long-term adherence to dietary changes is challenging, impacting sustained efficacy.
The relative contributions of specific nutrients versus overall caloric reduction remain incompletely defined.
Data on the comparative effectiveness of different dietary patterns in diverse populations are limited.
Adjunctive pharmacotherapy may be necessary in advanced disease or when lifestyle modification alone is insufficient.
How this may change practice
Clinicians should prioritize dietary counseling focused on Mediterranean-style or plant-based diets with emphasis on weight loss and metabolic health.
Incorporation of n-3 PUFA supplementation and encouragement of polyphenol-rich foods may provide additional benefit.
Multidisciplinary teams including dietitians and behavioral specialists can enhance adherence and outcomes.
Regular monitoring of liver function and metabolic parameters guides treatment adjustments.
Future guidelines will likely integrate precision nutrition approaches tailored to patient phenotypes and comorbidities.